Lapatinib Standard

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Lapatinib is an oral tyrosine kinase inhibitor used primarily in the treatment of HER2-positive breast cancer, targeting both EGFR (ErbB1) and HER2 (ErbB2) receptors to block cancer cell growth and proliferation.

Lapatinib Impurity 1

Lapatinib Impurity 4

Lapatinib Formyl Impurity

Lapatinib Deschloro Impurity

Lapatinib 4-Fluoro Analog

Lapatinib Carboxylic Acid Impurity

Address